DigiPath, Olympus ink digital pathology deal

Lisa Fratt | | Health Imaging | Enterprise Imaging
DigiPath and Olympus America have entered into a nonexclusive global agreement allowing DigiPath and its partners to access a portfolio of Olympus patents in the field of virtual microscopy and digital pathology.

The patents involved in the licensing agreement cover methods, software and technology for creating, storing and delivering virtual microscopy images, said Henderson, Nev.-based DigiPath, a digital pathology provider, and Center Valley, Pa.-based Olympus, which provides life science imaging systems.

Lisa Fratt

Related Content

Less than half of incidental interstitial lung abnormalities on CT exams are reported
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Rads are more accurate when they have access to patients' self-reported symptoms
AI-based software improves follow-up imaging adherence by 74%

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.